Skip to content

Analysis of the efficacy of microneedling combined with autologous platelet-rich plasma in the treatment of sensitive skin

Analysis of the efficacy of microneedling combined with autologous platelet-rich plasma in the treatment of sensitive skin

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095117
Enrollment
Unknown
Registered
2025-01-02
Start date
2025-01-10
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sensitive skin

Interventions

Experimental group:microneedling combined with autologous platelet-rich plasma

Sponsors

The Affiliated Hospital of Guangdong Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria in the Expert Consensus on the Diagnosis and Treatment of Sensitive Skin in China (2024); 2. Patients voluntarily participate in this study and sign the informed consent form; 3. Have not received photoelectric therapy or facial injection, filler and other treatments in the past six months; 4. Age> 18 years old.

Exclusion criteria

Exclusion criteria: 1. Those who have high expectations and are detached from reality; 2. Patients with open wounds or serious infection foci on the face, photosensitive skin diseases, and recent sunburn; 3. Patients with Progeria syndrome, bleeding disorders or immune diseases, endocrine diseases, malignant tumors and other serious systemic diseases; 4. Lactating or pregnant females; 5. Have bad habits such as drug abuse and travel history; 6. Scar constitution; 7. Those with coagulation disorder or recent use of anticoagulant drugs;

Design outcomes

Primary

MeasureTime frame
Total efficiency;

Secondary

MeasureTime frame
Pain score;GAIS;VISIA red zone;

Countries

China

Contacts

Public ContactCai Chuanchuan

The Affiliated Hospital of Guangdong Medical University

59162901@qq.com+86 13106641439

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026